Transforming Potential of Emerging Human Retroviruses

新兴人类逆转录病毒的转化潜力

基本信息

  • 批准号:
    7690756
  • 负责人:
  • 金额:
    $ 19.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-25 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human T cell leukemia virus type 1 (HTLV-1) was the first discovered pathogenic human retrovirus. HTLV-1, the etiologic agent of adult T cell leukemia (ATL), encodes a viral oncoprotein, Tax that is necessary and sufficient for viral transformation. HTLV-1 is the prototypic member of a human retrovirus family that also includes HTLV-2, which has not been definitively linked to any human disease. HTLV-1 and -2 are closely related to the simian T cell leukemia viruses, STLV-1 and -2, respectively. In 2005, the human homologue (HTLV-3) of a third simian retrovirus group, STLV-3, was independently isolated twice from Central African primate hunters, and a third independent isolation of HTLV-3 from humans was recently reported. The genome of the HTLV-3 (2026ND) isolate, in particular the Tax gene, is more closely related to HTLV-1 than to HTLV-2, especially in domains that are thought to be important for transformation. The broad distribution of STLV-3 in African primates and independent isolation of HTLV-3 multiple times from humans, suggest that HTLV-3 is prevalent in Africa. An additional human retrovirus, HTLV-4, was also isolated from an African primate hunter in 2005 and is distinct from all known HTLVs and STLVs. In contrast to HTLV-3, the HTLV-4 genome, in particular the Tax gene, is more closely related to HTLV-2 than to HTLV-1. This application is based on the hypothesis that the HTLV-3 Tax protein possesses oncogenic properties while the HTLV- 4 Tax protein does not. This hypothesis will be investigated in two specific aims that focus on determining the transforming potential, transcriptional activity, and protein interacting partners of the HTLV-3 and HTLV-4 Tax proteins. Since HTLV-3 and HTLV-4 appear to be emerging as new human retroviruses, it is critical that we determine the potential of these viruses to cause disease in humans. PUBLIC HEALTH RELEVANCE: Viruses are important causes of cancer in animals and in humans. One particular virus called HTLV-1 is known to cause a type of leukemia in humans. Two new viruses were recently found in humans and these new viruses are very closely related to HTLV-1. Therefore, we think that at least one of the new viruses may cause cancer in humans. HTLV-1 makes a protein called Tax that is necessary for the virus to cause cancer. We plan to compare the Tax protein made by HTLV-1, with the Tax protein made by each of the two new viruses so that we can determine whether the new viruses are likely to cause human cancer.
描述(由申请人提供):人类T细胞白血病病毒1型(HTLV-1)是第一个发现的病原体逆转录病毒。 HTLV-1是成年T细胞白血病(ATL)的病因学药物(ATL),它编码病毒果蛋白,税收,这对于病毒转化是必要且足够的税收。 HTLV-1是人类逆转录病毒家族的原型成员,该家族还包括HTLV-2,该家族尚未与任何人类疾病有关。 HTLV -1和-2分别与SIMIAN T细胞白血病病毒(STLV -1和-2)密切相关。 2005年,第三个拟南芥逆转录病毒组的人类同源物(HTLV-3)与中非灵长类动物的猎人独立隔离了两次,最近报道了第三个独立的HTLV-3独立隔离。 HTLV-3(2026nd)分离株的基因组,尤其是税收基因,与HTLV-1相比与HTLV-2更紧密相关,尤其是在被认为对转化很重要的领域中。 STLV-3在非洲灵长类动物中的广泛分布和HTLV-3从人类多次分离HTLV-3,这表明HTLV-3在非洲很普遍。 2005年,还从非洲灵长类动物的猎人中分离出了另外的人类逆转录病毒HTLV-4,与所有已知的HTLV和STLV不同。与HTLV-3相比,HTLV-4基因组,尤其是税收基因,与HTLV-2相比与HTLV-1更紧密相关。该应用基于以下假设:HTLV-3税蛋白具有致癌特性,而HTLV-4税蛋白不具有致癌特性。这一假设将在两个具体目的中进行研究,该目标侧重于确定HTLV-3和HTLV-4税收蛋白的转化潜力,转录活性以及蛋白质相互作用的伴侣。由于HTLV-3和HTLV-4似乎是新的人类逆转录病毒,因此我们必须确定这些病毒在人类中引起疾病​​的潜力至关重要。公共卫生相关性:病毒是动物和人类癌症的重要原因。已知一种称为HTLV-1的特定病毒会引起人类的一种白血病。最近在人类中发现了两种新病毒,这些新病毒与HTLV-1密切相关。因此,我们认为至少一种新病毒可能会导致人类癌症。 HTLV-1制造一种称为税收的蛋白质,是该病毒引起癌症所必需的。我们计划将HTLV-1的税收蛋白与两种新病毒的税收蛋白进行比较,以便我们可以确定新病毒是否可能引起人类癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN J MARRIOTT其他文献

SUSAN J MARRIOTT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN J MARRIOTT', 18)}}的其他基金

Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
开发新的小鼠模型来评估 HTLV 税收转型
  • 批准号:
    8637946
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:
Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
开发新的小鼠模型来评估 HTLV 税收转型
  • 批准号:
    8488975
  • 财政年份:
    2013
  • 资助金额:
    $ 19.19万
  • 项目类别:
Transforming Potential of Emerging Human Retroviruses
新兴人类逆转录病毒的转化潜力
  • 批准号:
    7455693
  • 财政年份:
    2008
  • 资助金额:
    $ 19.19万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    7350884
  • 财政年份:
    1999
  • 资助金额:
    $ 19.19万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    7213356
  • 财政年份:
    1999
  • 资助金额:
    $ 19.19万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6687008
  • 财政年份:
    1999
  • 资助金额:
    $ 19.19万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6876139
  • 财政年份:
    1999
  • 资助金额:
    $ 19.19万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6150322
  • 财政年份:
    1999
  • 资助金额:
    $ 19.19万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    2849538
  • 财政年份:
    1999
  • 资助金额:
    $ 19.19万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6497467
  • 财政年份:
    1999
  • 资助金额:
    $ 19.19万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
  • 批准号:
    10761853
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
  • 批准号:
    10709381
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
  • 批准号:
    10672785
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Automated lung sound analysis to improve the clinical diagnosis of pulmonary tuberculosis in children
自动肺音分析提高儿童肺结核的临床诊断
  • 批准号:
    10717389
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
感染和未感染艾滋病毒的幼儿结核感染的进展:PROTECT 研究
  • 批准号:
    10641389
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了